Stock SWAV SHOCKWAVE MEDICAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shockwave Medical

Equities

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Delayed Nyse
Other stock markets
 15:59:52 2024-05-30 EDT 		5-day change 1st Jan Change
334.8 USD -0.01% Intraday chart for Shockwave Medical +0.01% +75.69%
06-03 Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000 CI
06-03 Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 1,350 3,553 6,296 7,431 7,031
Enterprise Value (EV) 1 1,177 3,376 6,142 7,187 6,811
P/E ratio -20.5 x -52.2 x -685 x 36.1 x 49.5 x
Yield - - - - -
Capitalization / Revenue 31.4 x 52.4 x 26.5 x 15.2 x 9.63 x
EV / Revenue 27.4 x 49.8 x 25.9 x 14.7 x 9.33 x
EV / EBITDA -23.3 x -52.9 x 2,268 x 55.7 x 38.6 x
EV / FCF -34.8 x -59.5 x 3,739 x 145 x 60.6 x
FCF Yield -2.87% -1.68% 0.03% 0.69% 1.65%
Price to Book 7.17 x 15.9 x 26.1 x 14.6 x 10.5 x
Nbr of stocks (in thousands) 30,738 34,260 35,304 36,142 36,897
Reference price 2 43.92 103.7 178.3 205.6 190.6
Announcement Date 20-03-12 21-02-26 22-02-25 23-02-27 24-02-26
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2025 2026
Net sales 42.93 67.79 237.1 489.7 730.2 - -
EBITDA -46.86 -53.45 29.96 173.9 242.7 - -
EBIT -51.84 -65.66 -0.871 124.1 159.1 - -
Operating Margin -120.76% -96.86% -0.37% 25.35% 21.79% - -
Earnings before Tax (EBT) -51.05 -65.62 -8.835 120.8 174.3 - -
Net income -51.11 -65.7 -9.136 216 147.3 - -
Net margin -119.06% -96.92% -3.85% 44.1% 20.17% - -
EPS -2.140 -1.990 -0.2600 5.700 3.850 - -
Free Cash Flow - - 2.597 - 165.5 - -
FCF margin - - 1.1% - 22.66% - -
FCF Conversion (EBITDA) - - 8.67% - 68.18% - -
FCF Conversion (Net income) - - - - 112.34% - -
Dividend per Share - - - - - - -
Announcement Date 20-02-13 21-02-17 22-02-17 23-02-16 24-02-15 - -
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2025 2026
Net Debt - - - - - - -
Net Cash position 182 186 184 280 259 - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - 2.6 - 165 - -
ROE (net income / shareholders' equity) -146% -31.4% -3.91% 57.4% 25% - -
ROA (Net income/ Total Assets) - - - 43.6% 13.3% - -
Assets - - - 495.9 1,106 - -
Book Value Per Share 6.130 6.530 6.890 14.10 18.10 - -
Cash Flow per Share -2.010 -2.150 - 3.110 5.130 - -
Capex - - - 25.1 30.6 - -
Capex / Sales - - - 5.13% 4.19% - -
Announcement Date 20-02-13 21-02-17 22-02-17 23-02-16 24-02-15 - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
SHOCKWAVE MEDICAL Stock Shockwave Medical
+75.69% 12.57B
MASIMO CORPORATION Stock Masimo Corporation
+11.86% 7B
PENUMBRA, INC. Stock Penumbra, Inc.
-31.24% 6.78B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+9.17% 5.2B
GETINGE AB Stock Getinge AB
-20.22% 4.67B
APT MEDICAL INC. Stock APT Medical Inc.
+16.71% 4.26B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.04% 3.84B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-27.63% 2.7B
SKAN GROUP AG Stock SKAN Group AG
-0.99% 1.98B
NOVOCURE LIMITED Stock NovoCure Limited
+18.08% 1.95B
Medical Equipment
  1. Stock Market
  2. Equities
  3. SWAV Stock
  4. Financials Shockwave Medical